Day One Biopharmaceuticals
DAWN
DAWN
58 hedge funds and large institutions have $698M invested in Day One Biopharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
29% more funds holding
Funds holding: 45 → 58 (+13)
Holders
58
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$37.3M | |
| 2 | +$11.3M | |
| 3 | +$8.29M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.25M |
| 5 |
PCM
Pathway Capital Management
Irvine,
California
|
+$4.08M |
Top Sellers
| 1 | -$4.22M | |
| 2 | -$909K | |
| 3 | -$341K | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$253K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$114K |